Is there a survival benefit from increased intensity of CEA monitoring after primary resection of colorectal cancer?

Affiliations

¹ Clinical Operational Research Unit, University College London, London, UK; Clinical Trials Group, University College London, London, UK. Electronic address: tom.treasure@gmail.com.
² Wales Cancer Trials Unit, Cardiff University, Cardiff, UK.

Comment

T Treasure et al. Eur J Surg Oncol. 2016 Feb.

. 2016 Feb;42(2):312-3.

doi: 10.1016/j.ejso.2015.10.008. Epub 2015 Nov 2.

¹ Clinical Operational Research Unit, University College London, London, UK; Clinical Trials Group, University College London, London, UK. Electronic address: tom.treasure@gmail.com.
² Wales Cancer Trials Unit, Cardiff University, Cardiff, UK.

No abstract available

Comment in

Reply to: Is there survival benefit from increased intensity for CEA monitoring after primary resection of colorectal cancer?
Verberne CJ, Wiggers T. Verberne CJ, et al. Eur J Surg Oncol. 2016 Feb;42(2):314. doi: 10.1016/j.ejso.2015.10.007. Epub 2015 Nov 5. Eur J Surg Oncol. 2016. PMID: 26585466 No abstract available.

Intensified follow-up in colorectal cancer patients using frequent Carcino-Embryonic Antigen (CEA) measurements and CEA-triggered imaging: Results of the randomized "CEAwatch" trial.
Verberne CJ, Zhan Z, van den Heuvel E, Grossmann I, Doornbos PM, Havenga K, Manusama E, Klaase J, van der Mijle HC, Lamme B, Bosscha K, Baas P, van Ooijen B, Nieuwenhuijzen G, Marinelli A, van der Zaag E, Wasowicz D, de Bock GH, Wiggers T. Verberne CJ, et al. Eur J Surg Oncol. 2015 Sep;41(9):1188-96. doi: 10.1016/j.ejso.2015.06.008. Epub 2015 Jun 30. Eur J Surg Oncol. 2015. PMID: 26184850 Clinical Trial.